Loading
Latest filing published 19 Jun 2026 for enGene Therapeutics Inc., €216k. Read the official filing
No signal scores available.
Jill Yannetti Buck has a single filing on record, published on 19 June 2026: an option exercise of €216k in enGene Therapeutics Inc. One trade is not enough to describe a pattern. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration